Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RZV in Patients With Autoimmune Rheumatic Diseases
NCT05879419Phase 4Active, not recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- May 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in herpes zoster (HZ) (7 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Disease safety (flare) in ARD patients at 6 months, Effect of MTX discontinuation on immunogenicity at 1 year and 1 more. Started May 2023; status: active, not recruiting.
02
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05879419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05879419.